Therapies

New eye drop formulations are making dry eye treatment more affordable and accessible, especially for more severe sufferers. But Australia...

Australian optometrists are not permitted to prescribe oral medication, in contrast to comparative countries where their counterparts have been prescribing...

Prominent Melbourne retinal disease researcher Professor Robyn Guymer is encouraged by the Phase 3 results of a trial she’s been...

MIGS has triggered a shift in the glaucoma paradigm, enabling surgical intervention that bridges the gap between medical management and...

  The first corneal allogenic intrastromal ring segment (CAIRS) surgery in Australia has been performed at the Queensland Eye Institute...

A new paper comparing axial elongation differences among untreated myopes, myopes fitted with a control contact lens and emmetropes has...

Glaukos has secured Australian regulatory approval for the Preserflo MicroShunt, offering late-stage glaucoma patients a more elegant surgical alternative to...

Eight Australian researchers are taking their projects to the next level with a share of more than $1 million in...

As part of Macula Month this May, Insight examines drug development programs that could significantly alter the late-stage AMD therapy...

Australia’s first clinical trials of an investigational gene therapy for dry age-related macular degeneration (AMD) has commenced at the Centre...